Abstract-Low-salt diet is beneficial in salt-sensitive hypertension but may provoke cardiovascular risk in patients with heart failure, diabetes mellitus, or other cardiovascular abnormalities because of endogenous renin-angiotensin system activation. PPAR (peroxisome proliferator-activated receptor)-γ is a transcription factor which promotes an antioxidant pathway in the endothelium. We studied transgenic mice expressing a dominant-negative mutation in PPAR-γ selectively in the endothelium (E-V290M) to test the hypothesis that endothelial PPAR-γ plays a protective role in response to low salt-mediated renin-angiotensin system activation. Plasma renin and Ang II (angiotensin II) were significantly and equally increased in all mice fed low salt for 6 weeks. Vasorelaxation to acetylcholine was not affected in basilar artery from E-V290M at baseline but was significantly and selectively impaired in E-V290M after low salt. Unlike basilar artery, low salt was not sufficient to induce vascular dysfunction in carotid artery or aorta. Endothelial dysfunction in the basilar artery from E-V290M mice fed low salt was attenuated by scavengers of superoxide, inhibitors of NADPH oxidase, or blockade of the Ang II AT1 (angiotensin type-1) receptor. Simultaneous AT1 and AT2 receptor blockade revealed that the restoration of endothelial function after AT1 receptor blockade was not a consequence of AT2 receptor activation. We conclude that interference with PPAR-γ in the endothelium produces endothelial dysfunction in the cerebral circulation in response to low salt-mediated activation of the endogenous renin-angiotensin system, mediated at least in part, through AT1 receptor activation and perturbed redox homeostasis. Moreover, our data suggest that the cerebral circulation may be particularly sensitive to inhibition of PPAR-γ activity and renin-angiotensin system activation.
C ardiovascular diseases remain the leading cause of death in the United States despite advances in our understanding of its pathogenesis and treatment. 1 Reduced dietary sodium intake is recommended as a prophylactic approach to decrease the risk of cardiovascular diseases. 2 Although a low-salt diet (LSD) is beneficial in the context of salt-sensitive hypertension, accumulating evidence suggests that reducing salt intake stimulates the endogenous renin-angiotensin system (RAS), induces insulin resistance, increases lipid levels, and stimulates aldosterone and other stress hormones. 3, 4 Recent population-based studies indicate that salt restriction is associated with adverse health effects, particularly in patients with heart failure, diabetes mellitus, or other cardiovascular abnormalities. [5] [6] [7] Nonetheless, the mechanisms underlying the detrimental effects associated with reduced salt intake in certain patient populations are unclear.
Abnormal activation of the RAS has been implicated in an array of cardiovascular disorders, including hypertension and stroke. 8 A major regulatory system involved in maintenance of hemodynamic stability, the importance of the RAS is underscored by the sustained use of RAS blockers as primary treatments for hypertension. 9 Further, angiotensin receptor blockers have been clinically shown to reduce the risk of fatal stroke. 10 Similarly, ramipril, an angiotensin-converting enzyme inhibitor, was effective in lowering the incidence of stroke in patients with a history of cerebrovascular disease. 11, 12 Endothelial dysfunction is thought to be an independent predictor of cardiovascular events, and RAS blockers have been shown to restore endothelial function. 13 To date, the physiological mechanisms underlying the complex interactions between RAS activation and endothelial dysfunction have not been fully elucidated.
PPAR-γ (peroxisome proliferator-activated receptor-γ) is a ligand-activated transcription factor known to regulate anti-inflammatory and antioxidant signaling.
14 Synthetic agonists of PPAR-γ have been reported to reduce blood pressure, improve insulin sensitivity, and exert vascular protection. 15 In contrast, patients carrying an autosomal dominant mutation in PPAR-γ present with severe insulin resistance and early-onset hypertension. 16 Together, clinical and genetic evidence indicates a vital role for PPAR-γ in maintaining cardiovascular and metabolic homeostasis. To study the role of endothelial PPAR-γ, we generated mice (termed E-V290M) expressing a dominantnegative mutation in PPAR-γ selectively in the endothelium. E-V290M mice exhibit impaired vasodilation to acetylcholine when fed a high-fat diet or treated with subpressor dose of Ang II (angiotensin II) and exhibit increased inflammatory responses to cytokines. [17] [18] [19] PPAR-γ regulates the actions of Ang II in the vasculature, and genetic interference with PPAR-γ specifically in the endothelium impaired the responses of the cerebral basilar artery to Ang (1-7). [20] [21] [22] Moreover, some PPAR-γ mutations were reported to cause RAS activation. 23, 24 Thus, experimental evidence suggests that endothelial PPAR-γ plays a role in modulating the effects of RAS on endothelial function. We tested the hypothesis that endothelial PPAR-γ protects against endothelial dysfunction induced by activation of the endogenous RAS. We provide evidence that genetic interference with PPAR-γ in the endothelium produces endothelial dysfunction in the cerebral circulation in response to LSD-mediated activation of the endogenous RAS. Imbalance in redox homeostasis and AT1 (angiotensin type-1) receptor activation were identified as potential mediators of these effects.
Methods
Details of the experimental procedures for blood pressure measurements, vascular function studies using wire and pressurized myograph systems, use of inhibitors and receptor blockers, methods for RNA isolation, and real-time quantitative polymerase chain reaction are presented in the expanded Methods section in the online-only Data Supplement. The data from this study are available from the corresponding author upon reasonable request.
Animals
Adult male transgenic mice expressing a dominant-negative mutation in human PPAR-γ under the control of an endothelial-specific vascular cadherin promoter (E-V290M) were used as experimental models as reported. 17 Age-and sex-matched nontransgenic littermates were used as controls. A separate study is currently ongoing specifically studying endothelial function in female E-V290M mice and in male and female offspring from E-V290M and nontransgenic mice undergoing arginine vasopressin-induced preeclampsia. Nontransgenic and E-V290M mice were either fed TD.08290 (0.01%-0.02% Na; Teklad) 
Statistical Analysis
Results are expressed as mean±SEM. Statistical evaluation of the data was performed using GraphPad Prism. Data were analyzed using 1-way or 2-way ANOVA with repeated measures as appropriate, followed by Bonferroni or Tukey post hoc test as indicated in each figure legend. Differences were considered significant when P value was <0.05. Where appropriate individual data points are plotted in dot/whisker plots.
Results
Experimental and control mice were fed chow or LSD for 6 weeks. We measured circulating levels of renin and angiotensin peptides as an indicator of RAS activation. The levels of renin and angiotensin peptides were similar in nontransgenic and E-V290M mice fed chow ( Figure 1A and 1B). The levels of both renin and angiotensin peptides in plasma were significantly and similarly elevated in both nontransgenic and E-V290M mice after LSD. Consistent with our previous reports, E-V290M mice exhibited similar systolic blood pressure as nontransgenic controls at baseline which did not change in mice fed LSD ( Figure 1C ). 17, 18 At baseline, carotid arteries from nontransgenic and E-V290M mice exhibited similar concentration-dependent vasodilation to acetylcholine which were not affected by LSD (Figure 2A and 2B) . Similarly, endothelium-independent dilation to sodium nitroprusside was not altered in LSD-fed E-V290M mice compared with other groups ( Figure 2C and 2D) . Contractile responses to KCl, Ang II, serotonin (5-HT), and ET-1 (endothelin-1) were not altered in the carotid artery of E-V290M mice in response to activation of the endogenous RAS ( Figure S1 ). Vascular function studies performed on the aorta from these mice yielded similar results ( Figures S2 and S3) .
Cerebrovascular dysfunction has been implicated in cardiovascular disorders such as stroke and neurological conditions such as dementia and Alzheimer's disease. 25 Thus, we sought to study the cerebral basilar arteries which have previously been shown to be particularly sensitive to PPAR-γ mutations.
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Figure 1. Renin-angiotensin system (RAS) activation. A, Circulating levels of renin measured by ELISA in nontransgenic (NT) and E-V290M mice (NT chow, n=7; E-V290M chow, n=9; NT low-salt diet (LSD), n=8; E-V290M LSD, n=8). B, Plasma levels of angiotensin peptides measured by ELISA in NT and E-V290M mice (NT chow, n=9; E-V290M chow, n=9; NT LSD, n=8; E-V290M LSD, n=9). C, Systolic blood pressure measured using tail-cuff plethysmography in NT and E-V290M mice (n=6 per group). Systolic blood pressure was measured by tail cuff for 6 weeks after 3 weeks of training. Blood pressure was recorded 5 days per week for 6 weeks during the LSD. Data are presented as mean±SEM with individual data points shown and analyzed by 2-way ANOVA. *P<0.05 vs genotype-matched NT.
The baseline diameter of the basilar artery was not different between genotypes or in response to LSD (nontransgenic: chow, 163.3±4.9 versus LSD, 159.7±4.1 µm; E-V290M: chow, 174.5±11.4 versus LSD, 173.9±5.5 µm). Like larger vessels, responses of basilar artery to acetylcholine were not different in nontransgenic and E-V290M mice fed standard chow ( Figure 3A and 3B). LSD-induced activation of RAS did not affect endothelium-dependent relaxation responses in the basilar artery of nontransgenic mice. In contrast, acetylcholine-mediated vasodilation was significantly impaired in basilar artery from E-V290M mice fed LSD. Endotheliumindependent relaxation to sodium nitroprusside in the basilar artery was not significantly affected by either RAS activation or PPAR-γ genotype ( Figure 3C and 3D). Contraction to KCl was not altered in LSD-treated E-V290M mice ( Figure 3E ). There was a trend for decreased contraction to all doses of Ang II in basilar artery from mice fed LSD, but there was no difference between genotypes ( Figure 3F ).
PPAR-γ is known to have antioxidant properties, and we recently reported that interference with PPAR-γ in the endothelium induced Ang II-mediated endothelial dysfunction through an oxidative stress-dependent mechanism. 17 Therefore, we measured nitrotyrosine levels in the cerebral vessels from nontransgenic and E-V290M mice, as a marker of peroxynitrite generated from the reaction of nitric oxide with superoxide. 27 We observed that nitrotyrosine levels were significantly elevated in vessels from E-V290M mice fed an LSD, indicative of increased oxidative stress in the cerebral vasculature ( Figure 4A ). Consistent with this, endothelial function in the basilar artery was significantly improved in E-V290M mice incubated with the superoxide dismutase mimetic tempol ( Figure 4B ). To examine the underlying mechanism, we separately tested the effects of apocynin and VAS2870, 2 distinct inhibitors of NADPH oxidase.
Both apocynin and VAS2870 had no effect on the relaxation responses to acetylcholine in nontransgenic mice but significantly improved endothelial function in the basilar artery from E-V290M mice fed LSD ( Figure 4C and 4D) . NADPH oxidase is composed of a catalytic subunit Nox2 (NADPH oxidase subunit 2), phox (p22 phagocyte oxidase), and regulatory subunits p47 phox , p67 phox , p40 phox , and Rac (Rho-like GTPases). 28 Of these regulatory subunits, phosphorylation of p47 phox is known to be required for the activation of NADPH oxidase.
29 Therefore, we measured the level of phosphorylated p47 phox in the cerebral vessels of nontransgenic and E-V290M mice. Phosphorylated p47 phox was significantly elevated in E-V290M mice fed an LSD compared with other groups, confirming NADPH oxidase activation and subsequent ROS generation ( Figure 4E) .
We measured the level of expression of genes related to oxidative stress in the cerebral vasculature by real-time quantitative polymerase chain reaction. The expression levels of NADPH oxidase subunit Nox2, NF-κB (nuclear factor-kappa B) subunit p65, eNOS (endothelial nitric oxide synthase), and the antioxidant enzymes SOD1 (superoxide dismutase 1), SOD3, and catalase were similar in the cerebral vessels from chow-fed nontransgenic and E-V290M mice ( Figure 5 ). Expression of Nox2 was increased, whereas expression of catalase and SOD3 was both decreased in basilar artery from E-V290M mice fed LSD. There were no differences in the expression levels of p65, eNOS, or SOD1. Altogether, this suggests that oxidative stress in basilar artery from E-V290M mice fed LSD may be mediated through increased NADPH oxidase and reduced antioxidant gene expression.
Because abnormal activation of the RAS is known to induce generation of ROS via an AT1 receptor-dependent mechanism, we hypothesized that the endothelial dysfunction observed in the basilar artery of E-V290M mice was mediated through AT1 receptors. To test this, we treated LSD-fed nontransgenic and E-V290M mice with Losartan for 3 weeks. Losartan treatment robustly increased plasma renin in nontransgenic and E-V290M mice, presumably because of relief of the classic negative feedback pathway ( Figure 6A) . Importantly, the increase in renin in response to losartan was the same in nontransgenic and E-V290M mice. There was a significant and similar reduction in systolic blood pressure in both losartan-treated LSD-fed nontransgenic and E-V290M mice compared with genotype-matched mice fed an LSD alone ( Figure 6B ). We then assessed vasodilation responses to acetylcholine in the basilar artery after losartan administration. Replicating the data above, this independent cohort of E-V290M mice fed an LSD exhibited impaired vasodilation to acetylcholine ( Figure 6C ). Acetylcholine-mediated relaxation was significantly improved, and maximal relaxation to acetylcholine was normalized in the basilar arteries from losartan-treated E-V290M mice fed LSD ( Figure 6C and 6D) , suggesting that the endothelial dysfunction induced by RAS activation is dependent on AT1 receptors. We next measured the expression of AT1 receptor mRNA in the cerebral arteries of these mice, and we observed that regardless of diet, the levels of AT1 receptor mRNA were not different in the cerebral arteries of nontransgenic and E-V290M mice ( Figure 6E) . Thus, the improved endothelial function under AT1 receptor blockade in E-V290M mice fed LSD was not because of increased expression of AT1 receptor mRNA.
AT1 receptor antagonism has been previously shown to exert protective effects in the vasculature through activation of AT2 receptors. 30 Therefore, we investigated if the restoration of endothelial function in the cerebral vasculature from losartantreated E-V290M mice was the result of AT1 receptor blockade or because of concomitant AT2 receptor activation. Thus, we examined relaxation responses to acetylcholine in the basilar artery from nontransgenic and E-V290M mice treated with both losartan and PD123319, an AT2 receptor antagonist ( Figure 6F ). The improvement in acetylcholine-induced relaxation observed on AT1 receptor blockade was not affected by simultaneous blockade of AT2 receptors, suggesting that the restoration of endothelial function in the basilar artery of E-V290M mice was not a consequence of AT2 receptor activation. 
Discussion
The salient findings of the present study are that (1) genetic interference with PPAR-γ in the endothelium did not affect endothelial function in cerebral basilar arteries from mice fed chow but augmented the effects of LSD-mediated endogenous RAS activation causing endothelial dysfunction, (2) the effects on endothelial function in response to PPAR-γ mutation and activation of RAS after a 6-week LSD regimen were minimal in carotid arteries and aorta, (3) endothelial dysfunction in the basilar artery of E-V290M mice was prevented by a scavenger of superoxide or inhibitors of NADPH oxidase, (4) RAS-induced impairment in endothelial function in the basilar artery was dependent on AT1 receptor activation, and (5) improvement in endothelial function on AT1 receptor blockade was not a consequence of AT2 receptor activation. Together, these findings highlight the effect of endogenous RAS activation particularly on the cerebral vasculature and provide novel insights into the mechanisms by which endothelial PPAR-γ protects against endothelial dysfunction induced by the normal activation of the RAS caused in response to salt restriction.
The RAS plays a key role in the regulation of fluid balance and electrolyte homeostasis in the body. Individual components of the RAS have been well studied, and their importance has been documented in preclinical and clinical models of cardiovascular diseases. 31 A major factor regulating endogenous RAS activity is salt intake, and high salt consumption has been widely associated with increased risk of cardiovascular diseases such as hypertension. 32 In the United States, sodium intake exceeds recommended amounts across all age groups and race. Limiting sodium intake to 2300 mg/d has been a consistent dietary recommendation for decades. 33 Recent propositions of a further reduction in daily sodium consumption to 1500 mg/d have been made in the Dietary Approaches to Stop Hypertension (DASH dietary pattern); nevertheless, the feasibility and benefits of these reductions have been questioned and are still debatable at least among specific population subgroups who are at risk of developing cardiovascular disorders. In clinics, sodium restriction has been effective in patients with salt-sensitive hypertension. 34 This has led to a popular notion that reducing salt intake is beneficial for cardiovascular diseases in general. However, recent epidemiological studies reported that salt restriction is associated with adverse effects in patients with cardiovascular abnormalities and diabetes mellitus. [5] [6] [7] This may be because of the activation of the endogenous RAS as higher plasma renin levels have been previously associated with myocardial infarction and increased mortality and morbidity in patients with coronary artery disease. 35 Consistent with this, we show that an LSD induced the endogenous RAS, and notably, this induction was similar irrespective of the PPAR-γ genotype. As previously reported by our laboratory, interference with PPAR-γ in the endothelium through targeted expression of a dominant-negative mutation in PPAR-γ has no effect under baseline conditions but results in oxidative stress and endothelial dysfunction in cerebral basilar arteries in response to high-fat diet, subpressor doses of Ang II, and most recently in aging. 17, 18, 22 Our previous studies combined with the current study imply that resistance vessels may be more sensitive to the loss of PPAR-γ activity and compared with conduit arteries when the mice are also subjected to another cardiovascular stressor. The actual mechanism for this difference remains unclear. Nevertheless, these data underscore the critical role played by endothelial PPAR-γ in protecting against accelerated cerebral vascular dysfunction induced by a host of cardiovascular risk factors including sodium restriction.
In humans, activation of PPAR-γ lowers arterial blood pressure and dominant-negative PPAR-γ mutations cause impaired PPAR-γ function and hypertension. 15, 16 This strongly supports the physiological significance of PPAR-γ and exemplifies the severe consequences for cardiovascular events when PPAR-γ signaling is impaired. The use of mice expressing human disease-causing mutations increases the relevance to human diseases and provides greater mechanistic insights into the protective role of PPAR-γ in the endothelium because we can manipulate PPAR-γ signaling in a cell-specific manner. We view this as a strength of the current study. PPAR-γ is normally expressed in the endothelium and smooth muscle where it has been shown to exhibit anti-inflammatory and antioxidant properties. 17 Previous studies have linked dysregulation of the RAS and oxidative stress with cerebrovascular dysfunction associated with aging and cardiovascular diseases. 36 Ang II has been shown to activate pro-oxidant and proinflammatory signaling that generates reactive oxygen species and causes vascular diseases. 37 Our data that mice expressing dominantnegative PPAR-γ in the endothelium exhibited oxidative stress-dependent endothelial dysfunction in response to sodium restriction expand this concept. Further, consistent with previous reports of increased NADPH oxidase components in these mice, incubation of the basilar artery from E-V290M mice with apocynin and VAS2870 restored endothelial function. 17 Although our data suggest a role for superoxide generated primarily by NADPH oxidase, the involvement of other sources of superoxide and even other reactive oxygen species such as peroxides cannot be ruled out. In this light, the decrease in expression of antioxidant enzymes catalase and SOD3 in the basilar artery of E-V290M mice suggests a role for an impaired antioxidant defense mechanism in response to RAS activation. The fact that catalase and SOD3 are PPAR-γ target genes further highlights the significance of PPAR-γ in the regulation of endothelial function and provides mechanistic insights into cerebral endothelial dysfunction induced by RAS activation. 18, 38 In addition to oxidative stress, previous studies in animal models exhibiting impaired vascular function associated with RAS activation have illustrated the significance of Figure 6 . Endothelial function in basilar artery: role of AT1 and AT2 receptors. A, Circulating levels of renin measured by ELISA in low-salt diet (LSD)-fed nontransgenic (NT) and E-V290M mice in response to Losartan (Los) administration (NT LSD, n=6; E-V290M LSD, n=6, NT LSD+Los, n=5; E-V290M LSD+Los, n=6), *P<0.05 LSD vs LSD+Los. B, Systolic blood pressure (SBP) measured using tailcuff plethysmography in LSD-fed NT and E-V290M mice in response to Losartan administration (NT LSD, n=5; E-V290M LSD, n=6, NT LSD+Los, n=5; E-V290M LSD+Los, n=6), *P<0.05 LSD vs LSD+Los. C, Cumulative concentration-response curves for acetylcholine (ACh) and (D) maximum relaxation to ACh in basilar arteries from LSD-fed NT (n=5) and E-V290M mice (n=5)±losartan. E, mRNA expression levels of the AT1R gene in pooled cerebral vessels from NT and E-V290M mice fed an LSD or standard chow (n=6 per group). F, Cumulative concentration-response curves for ACh in basilar arteries from LSD-fed NT (n=4) and E-V290M mice (n=4)+losartan±PD123319. Data are presented as mean±SEM analyzed by 2-way ANOVA (A, E) or 2-way ANOVA with repeated measures (B-D, F). *P<0.05 E-V290M LSD vs all other groups.
AT1 receptors in mediating endothelial dysfunction. 39 Most of the detrimental effects of Ang II on vascular beds have been attributed to its actions via the AT1 receptor. In the cerebral circulation, circulating and locally produced Ang II acts via AT1 receptors in cerebral arteries and capillaries and is known to participate in the regulation of cerebral blood flow and cerebrovascular function. 40 Chronic activation of the AT1 receptor in the cerebral vasculature has been shown to contribute to inflammation which in turn leads to cerebrovascular remodeling and impaired cerebrovascular function. 41, 42 Furthermore, administration of losartan, a selective and competitive inhibitor of AT1 receptors, has been previously shown to improve vascular reactivity in cerebral arteries in preclinical models associated with vascular oxidative stress. 43 Interestingly, our data that impaired vasodilation to acetylcholine in the basilar artery of LSD-treated E-V290M mice was improved by losartan are consistent with these findings. The efficacy of losartan treatment in this study was validated by the substantial elevation in circulating renin levels and the lowered blood pressure in LSD-fed nontransgenic and E-V290M mice. Importantly, blood pressure was equally lowered in nontransgenic and E-V290M mice, suggesting that the improvement in endothelial function by AT1 receptor blockade was not a consequence of decreased blood pressure. Moreover, our data suggest a potential mechanism by which endothelial PPAR-γ exerts protective effects on cerebral endothelial function by combating the pro-oxidant effects induced by elevated AT1 receptor activation under salt-restricted conditions. Although blockade of AT1 receptor is beneficial in improving endothelial function in E-V290M mice, it is worth mentioning that RAS-blocking drugs may be harmful in excessively salt-restricted cardiovascular patients who have high plasma renin levels as the elevation in circulating levels of renin might be required to prevent hypotension, hyperkalemia, and reduced glomerular filtration rates. 44, 45 These results highlight the potential detrimental effects of excessive and chronic AT1 receptor activation, resulting from sodium restriction in the cerebral vascular function. Nevertheless, we recognize that the very low level of sodium in the diet used in this study may cause abnormally low sodium balance (severe sodium depletion) and may represent a weakness. Thus, additional studies with intermediate levels of sodium restriction may be warranted.
Angiotensin receptor blockers such as losartan antagonize Ang II at its AT1 receptor but do not affect the AT2 receptor subtype when administered in recommended concentrations. AT2 receptors have unique and predominantly oppositional effects than that of AT1 receptors on blood vessels. 46 During stress-related events, such as vascular injury and even sodium depletion, AT2 receptors are thought to be upregulated to oppose the pathological effects mediated by the AT1 receptor subtype. 47 Therefore, we investigated if the losartan-mediated improvement in endothelial dysfunction observed in the E-V290M was a result of AT2 receptor activation. Our data illustrating improved endothelial relaxation to acetylcholine in the basilar artery of E-V290M mice on simultaneous blockade of AT1 and AT2 receptors rule out a plausible protective effect mediated by AT2 receptor activation in the cerebral arteries under low sodium conditions.
Perspectives
Although limiting dietary sodium consumption is beneficial in salt-sensitive hypertension, several lines of evidence suggest that it causes serious health consequences in certain patient populations, mostly as a result of off-target effects such as endogenous RAS activation. Herein, our data indicate that in conditions with impaired PPAR-γ activity, which can occur in obesity, diabetes mellitus, and other associated cardiovascular abnormalities, RAS activation induced by a low sodium diet might increase the susceptibility to endothelial dysfunction, particularly in smaller cerebral arteries.
Recent results from SPRINT (Systolic Blood Pressure Intervention Trial) suggest that reductions in diastolic blood pressure offer strong health benefits in non-diabetic individuals who are at risk for increased cardiovascular morbidities. 48 In contrast, patients with type-2 diabetes mellitus were reported to have an increased cardiovascular mortality that was paradoxically associated with lower excretion of urinary sodium, and alarmingly, the highest mortality rate was observed in patients with diabetes mellitus with the lowest sodium intake. 49 Although these recent reports are highly specific to certain subpopulations, it is indeed understandable that these high-risk patient populations are the ones where such aggressive dietary interventions are prescribed. Further studies in this area may facilitate therapeutic approaches that could be used to prevent the offtarget deleterious effects of sodium restriction in these populations.
